Breast cancer is the most common malignancy in women, and neoadjuvant chemotherapy has been recommended to the patients with locally advanced breast cancer as the initial treatments. | Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer